Abstract CT146: RGX-104, a first-in-class immunotherapy targeting the liver-X receptor (LXR): Initial results from the phase 1b RGX-104 plus docetaxel combination dose escalation c... von Lim, Emerson, Hamilton, Erika P., Redman, Rebecca, Postow, Michael A., Schilder, Russell J., Mita, Monica M., Mita, Alain C., Chmielowski, Bartosz, Strauss, James, Jain, Angela, Pant, Shubham, Rixe, Olivier, Dragovich, Tomislav, Harvey, R. Donald, Puzanov, Igor, Kim, Kevin B., Rowinsky, Eric K., Szarek, Michael, Gonsalves, Foster, Kurth, Isabel, Andreu, Celia, Busby, Robert W., Darst, David, Tavazoie, Masoud, Raza, Syed, Lebaka16, Narayan, Wasserman, Robert, Falchook, Gerald

Volltext